Spots Global Cancer Trial Database for Post Market Study Using the Xoft Axxent System
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Post Market Study Using the Xoft Axxent System
Official Title: Post Market Clinical Study to Evaluate the Safety and Performance of the Axxent® Electronic Brachytherapy System in Women With Resected, Early Stage Breast Cancer
Study ID: NCT01017549
Conditions
Interventions
Study Description
Brief Summary: The purpose of this multi-center clinical study is to compile post market performance and safety data on the Axxent System.
Detailed Description: The purpose of this multi-center clinical study is to compile post market performance and safety data on the Axxent System for the delivery of radiation therapy as part of breast conserving therapy in women with resected, early stage breast cancer.
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Mills Peninsula Hospital, San Mateo, California, United States
Wellstar-Kennestone Cancer Center, Marietta, Georgia, United States
Rush University Medical Center, Chicago, Illinois, United States
Little Company of Mary Hospital, Evergreen Park, Illinois, United States
Holy Cross Medical Center, Silver Spring, Maryland, United States
Beth Israel Medical Center, New York, New York, United States
Dickstein Cancer Center- White Plains Hospital, White Plains, New York, United States
Oklahoma University Health Science Center, Oklahoma City, Oklahoma, United States
Rhode Island Hospital, Providence, Rhode Island, United States
Swedish Cancer Institute, Seattle, Washington, United States
Contact Details
Name: Vivek K Mehta, MD
Affiliation: Swedish Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
